Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2137 | 2275 | 40.2 | 82% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1985 | 5079 | 11 BETA HYDROXYSTEROID DEHYDROGENASE//ALDOSTERONE//EPLERENONE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | 11 BETA HYDROXYSTEROID DEHYDROGENASE | Author keyword | 384 | 70% | 14% | 322 |
2 | 11 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1 | Author keyword | 183 | 84% | 4% | 98 |
3 | 11 BETA HSD1 | Author keyword | 119 | 75% | 4% | 85 |
4 | MOL HYPERTENS | Address | 63 | 81% | 2% | 38 |
5 | GLUCOCORTICOID METABOLISM | Author keyword | 40 | 77% | 1% | 27 |
6 | 11 BETA HSD2 | Author keyword | 39 | 61% | 2% | 42 |
7 | HEXOSE 6 PHOSPHATE DEHYDROGENASE | Author keyword | 30 | 79% | 1% | 19 |
8 | 11 BETA HSD1 INHIBITOR | Author keyword | 29 | 88% | 1% | 14 |
9 | CORTISONE | Author keyword | 29 | 32% | 3% | 74 |
10 | 11 BETA HYDROXYSTEROID DEHYDROGENASE 1 | Author keyword | 23 | 79% | 1% | 15 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | APPARENT MINERALOCORTICOID EXCESS | 360 | 66% | 15% | 338 |
2 | CORTICOSTEROID 11 BETA DEHYDROGENASE | 337 | 91% | 6% | 143 |
3 | CORTISOL METABOLISM | 185 | 73% | 6% | 143 |
4 | 11 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1 | 168 | 39% | 15% | 336 |
5 | HEPATIC INSULIN SENSITIVITY | 148 | 74% | 5% | 108 |
6 | HEXOSE 6 PHOSPHATE DEHYDROGENASE | 143 | 73% | 5% | 111 |
7 | BETA HYDROXYSTEROID DEHYDROGENASE | 132 | 51% | 8% | 187 |
8 | 11 BETA DEHYDROGENASE | 94 | 89% | 2% | 42 |
9 | 11 BETA HSD1 INHIBITORS | 85 | 92% | 1% | 34 |
10 | II ENZYME | 79 | 94% | 1% | 29 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
11 beta-HYDROXYSTEROID DEHYDROGENASES: INTRACELLULAR GATE-KEEPERS OF TISSUE GLUCOCORTICOID ACTION | 2013 | 47 | 735 | 64% |
11 beta-hydroxysteroid dehydrogenase type 1: A tissue-specific regulator of glucocorticoid response | 2004 | 518 | 358 | 76% |
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders? | 2013 | 24 | 103 | 75% |
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis | 2009 | 220 | 125 | 37% |
11 beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action | 2005 | 210 | 152 | 88% |
11 beta-Hydroxysteroid Dehydrogenase 1: Translational and Therapeutic Aspects | 2013 | 21 | 295 | 69% |
11 beta-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Hypothalamus-Pituitary-Adrenal Axis, Metabolic Syndrome, and Inflammation | 2009 | 69 | 96 | 91% |
11 beta-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus | 2012 | 24 | 162 | 80% |
11 beta-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess | 1997 | 386 | 183 | 75% |
11 beta-hydroxysteroid dehydrogenase | 1999 | 326 | 338 | 72% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL HYPERTENS | 63 | 81% | 1.7% | 38 |
2 | MOL SYST TOXICOL | 20 | 47% | 1.4% | 31 |
3 | MED CHEM CLIN PHARM | 7 | 50% | 0.4% | 10 |
4 | REG ENDOCRINE UNIT | 7 | 41% | 0.6% | 13 |
5 | DEV ENDOCRINE SIGNALLING | 4 | 42% | 0.4% | 8 |
6 | QUEEN ELIZABETH HOSP MED | 4 | 56% | 0.2% | 5 |
7 | ASSAY DEV SCREENING | 3 | 39% | 0.3% | 7 |
8 | MOLEC HYPERTENS | 3 | 100% | 0.1% | 3 |
9 | UFR MED SECTEUR NORD | 3 | 100% | 0.1% | 3 |
10 | CIHR GRP DEV FETAL HLTH | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000109930 | HIGH BLOOD P SURE UNIT//ADRENOCORTICOTROPHIC HORMONE//GLUCOCORTICOID INDUCED HYPERTENSION |
2 | 0.0000083036 | DEFLAZACORT//GLUCOCORTICOID INDUCED DIABETES//STEROID DIABETES |
3 | 0.0000072298 | ALDOSTERONE//EPLERENONE//SPIRONOLACTONE |
4 | 0.0000063759 | 6 BETA HYDROXYCORTISOL//PARTIAL COMPONENT REGRESSION//GLOBAL QUAL SERV ANALYT SCI |
5 | 0.0000060346 | 19 NORDEOXYCORTICOSTERONE//ADRENAL RENAL PORTAL CIRCULATION//19 NORALDOSTERONE |
6 | 0.0000054991 | GLYCYRRHIZIN//LICORICE//GLABRIDIN |
7 | 0.0000049650 | STUDIES REPROD//MED STUDIES REPROD PHYSIOL//FETAL ZONE |
8 | 0.0000048782 | HAIR CORTISOL//CIHR GSK CHAIR PEDIAT CLIN PHARMACOL//OBES CGG |
9 | 0.0000044017 | 17 BETA HYDROXYSTEROID DEHYDROGENASE//17 BETA HSD2//17 BETA HSD1 |
10 | 0.0000043608 | GLUCOCORTICOID RECEPTOR//GLUCOCORTICOID RESISTANCE//TRANSREPRESSION |